These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 12296605)
21. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
22. Genetic causes of familial hypercholesterolaemia in a Malaysian population. Khoo KL; Van Acker P; Tan H; Deslypere JP Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151 [TBL] [Abstract][Full Text] [Related]
23. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia. Sachais BS; Katz J; Ross J; Rader DJ J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364 [TBL] [Abstract][Full Text] [Related]
24. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
25. Review of efficacy of rosuvastatin 5 mg. Teramoto T; Watkins C Int J Clin Pract; 2005 Jan; 59(1):92-101. PubMed ID: 15707472 [TBL] [Abstract][Full Text] [Related]
26. Assessment of functional low-density lipoprotein receptor activity on lymphocytes of normal subjects and patients with familial hypercholesterolemia. Cuthbert JA; Lipsky PE Trans Assoc Am Physicians; 1988; 101():1-11. PubMed ID: 3269672 [TBL] [Abstract][Full Text] [Related]
27. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin. Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M; Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541 [TBL] [Abstract][Full Text] [Related]
28. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia. Miltiadous G; Cariolou MA; Elisaf M Ann Clin Lab Sci; 2002; 32(1):50-4. PubMed ID: 11848618 [TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of familial hypercholesterolaemia. Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791 [TBL] [Abstract][Full Text] [Related]
30. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy. Duvall WL; Blazing MA; Saxena S; Guyton JR J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203 [TBL] [Abstract][Full Text] [Related]
31. [Is detection and treatment of familial hypercholesterolemia indicated in children?]. Bakker HD; Wiegman A; Defesche JC; Kastelein JJ Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154 [TBL] [Abstract][Full Text] [Related]
32. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting. Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504 [TBL] [Abstract][Full Text] [Related]
33. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment. Kwiterovich PO Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219 [TBL] [Abstract][Full Text] [Related]
34. NLA Symposium screening and treatment of familial hypercholesterolemia: how can we do better? Opening and introductions. McGowan M J Clin Lipidol; 2010; 4(5):335-7. PubMed ID: 21122673 [TBL] [Abstract][Full Text] [Related]
35. Relationship between LDL receptor activity and development of coronary heart disease in Japanese cases with heterozygous familial hypercholesterolemia. Yamashita S; Kawamoto T; Ueyama Y; Funahashi T; Hara H; Hirobe K; Matsuzawa Y; Yamamoto A; Tarui S Artery; 1987; 15(1):24-43. PubMed ID: 3435251 [TBL] [Abstract][Full Text] [Related]
36. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia]. Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035 [TBL] [Abstract][Full Text] [Related]
37. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor. Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613 [TBL] [Abstract][Full Text] [Related]
38. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia. van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431 [TBL] [Abstract][Full Text] [Related]
39. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
40. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks. McKenney JM Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]